Due to the introduction of antacids, histamine H2-receptor antagonists, proton pump inhibitors, and the eradication of H. pylori, the paradigm of peptic ulcer disease has changed drastically, with a marked decrease in morbidity and mortality [39]–[40]. Here, HRH2 is linked to peptic ulcer disease.